Recombinant hydrophilic human gp100: Uptake by dendritic cells and stimulation of autologous CD8+ lymphocytes from melanoma patients

Immunology Letters

Volumn 94, Issue 3, 2004, Pages 253-259

  Frankenburg, Shoshana ^a   Elias, Orit ^a   Gelbart, Yamit ^b   Drize, Olga ^a   Lotem, Michal ^a   Ingber, Arieh ^a   Peretz, Tamar ^a   Pitcovski, Jacob ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

Author keywords

CD8+ lymphocytes; Dendritic cells; Human gp100

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 100; RECOMBINANT PROTEIN;

ARTICLE; BACTERIUM; CELL INTERACTION; CELL KILLING; CELL STIMULATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; LYMPHOCYTE; MELANOMA; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; TARGET CELL; YEAST;

CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HUMANS; INTERFERON TYPE II; MELANOMA; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; PICHIA; RECOMBINANT PROTEINS;

EID: 3242714046     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.05.014     Document Type: Article

References (25)

1. Chen YT, Old LJ. Cancer-testis antigens: targets for cancer immunotherapy. Cancer J Sci Am 1999;16-17.
2. Bakker A.B., Schreurs M.W., de Boer A.J., Kawakami Y., Rosenberg S.A., Adema G.J., Figdor C.G. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179:1994;1005-1009
3. Kawakami Y., Eliyahu S., Sakaguchi K., et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor-infiltrating lymphocytes. J. Exp. Med. 180:1994;347-350
4. Cox A.L., Skipper J., Chen Y., Henderson R.A., Darrow T.L., Shabanowitz J., Engelhard V.H., Hunt D.F., Slingluff C.L. Jr. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science. 264:1994;716-719
5. Kawakami Y., Eliyahu S., Jennings C., et al. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor infiltrating lymphocytes associated with in vivo tumor regression. J. Immunol. 154:1995;3961-3968
6. Phan G.Q., Touloukian C.E., Yang J.C., Restifo N.P., Sherry R.M., Hwu P., Topalian S.L., Schwartzentruber D.J., Seipp C.A., Freezer L.J., Morton K.E., Mavroukakis S.A., White D.E., Rosenberg S.A. Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens. J. Immunother. 26:2003;349-356
7. Amoscato A.A., Prenovitz D.A., Lotze M.T. Rapid extracellular degradation of synthetic class I peptides by human dendritic cells. J. Immunol. 16:1998;4023-4032
8. Ludewig B., McCoy K., Pericin M., Ochsenbein A.F., Dumrese T., Odermatt B., Toes R.E.M., Melief C.J.M., Hengartner H., Zinkernagel R.M. Rapid peptide turnover and inefficient presentation of exogenous antigen critically limit the activation of self-reactive CTL by dendritic cells. J Immunol. 166:2001;3678-3687
9. Jaeger E., Ringhoffer M., Karbach J., Arand M., Oesch F., Knuth A. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo. Int. J. Cancer. 66:1996;470-476
10. Riker A., Cormier J., Panelli M., Kammula U., Wang E., Abati A., Fetsch P., Lee K.H., Steinberg S., Rosenberg S., Marincola F. Immune selection after antigen-specific immunotherapy of melanoma. Surgery. 126:1999;112-120
11. Finn O.J. Cancer vaccines: between the idea and the reality. Nat. Rev. Immunol. 8:2003;630-641
12. Lapointe R., Royal R.E., Reeves M.E., Altomare I., Robbins P.F., Hwu P. Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100. J. Immunol. 167:2001;4758-4766
13. Wan Y., Emtage P., Zhu Q., Foley R., Pilon A., Roberts B., Gauldie J. Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells. Cell Immunol. 198:1999;131-138
14. Riker A.I., Kammula U.S., Panelli M.C., Wang E., Ohnmacht G.A., Steinberg S.M., Rosenberg S.A., Marincola F.M. Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes. Int. J. Cancer. 86:2000;818-826
15. Cochlovius B., Linnebacher M., Zewe-Welschof M., Zoller M. Recombinant gp100 protein presented by dendritic cells elicits a T-helper-cell response in vitro and in vivo. Int. J. Cancer. 83:1999;547-554
16. Parkhurst M.R., DePan C., Riley J.P., Rosenberg S.A., Shu S. Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules. J. Immunol. 170:2003;5317-5325
17. Gelbart Y.S., Frankenburg Y., Pinchasov S., Krispel D., Eliahu O., Drize E., Morag D., Bartfeld M., Lotem T., Pitcovski J. Production and purification of melanoma gp100 antigen and polyclonal antibodies. Protein Expr Purif. 34:2004;183-189
18. Pitcovski J., Gutter B., Gallili G., Goldway M., Perelman B., Gross G., Krispel S., Barbakov M., Michael A. Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens. Vaccine. 21:2003;4736-4743
19. Lotem M., Peretz T., Drize O., Gimmon Z., Ad El D., Weitzen R., Goldberg H., Ben David I., Prus D., Hamburger T., Shiloni E. Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer. Br. J. Cancer. 86:2002;1534-1539
20. Rieser C., Bock G., Klocker H., Bartsch G., Thurnher M. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J. Exp. Med. 186:1997;1603-1608
21. Jonuleit H., Kuhn U., Muller G., Steinbrink K., Paragnik L., Schmitt E., Knop J., Enk A.H. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27:1997;3135-3142
22. Moretta L., Romagnani C., Pietra G., Moretta A., Mingari M.C. NK-CTLs, a novel HLA-E-restricted T-cell subset. Trends Immunol. 24:2003;136-143
23. Vincent M.S., Gumperz J.E., Brenner M.B. Understanding the function of CD1-restricted T cells. Nat. Immunol. 4:2003;517-523
24. Touloukian C.E., Leitner W.W., Topalian S.L., Li Y.F., Robbins P.F., Rosenberg S.A., Restifo N.P. Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice. J. Immunol. 164:2000;3535-3542
25. Kierstead L.S., Ranieri E., Olson W., Brusic V., Sidney J., Sette A., Kasamon Y.L., Slingluff C.L., Kirkwood J.M., Storkus W.J. gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells. Br. J. Cancer. 85:2001;1738-1745